Needham Keeps 'Buy' on Scios
Analyst Mark Monane believes the drug maker's Natrecor heart medication will be approved by the FDA in July 2001
Needham reiterates buy on shares of Scios (SCIO ).
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.
You might like: